CSuite Focus — representing the leading CFOs, CEOs, CHROs and other “csuiters” in the region, is joining forces with BioMedLey to highlight the region’s life science leaders. Join us and meet our special guests including

• California Lutheran University’s new President Dr John Nunes, PhD
• Stephen Hatke, VP, Manufacturing Operations, Takeda
• Yasser Hazzaa, VP Finance & Treasurer, MannKind Corporation
• Nikita M. Shah M.D., Breast Surgical Oncologist, City of Hope & Adventist Health Simi Valley
• Latha Vairavan, VP, & Controller, Arcutis Biotherapeutics
• Thomas Zindrick, Chair and CEO, Genelux Corporation

We’ll gather with these stars under the stars at Vallavanda, a beautiful mountaintop estate above Santa Rosa Valley

Ryan Goble from the Beverly Hills Fire Department demos CPR and defib — grab a drink, save a life!

Amgen and other biotechs are creating miracle cures and providing terrific jobs off the 101 between LA and Santa Barbara.

But is the industry sustainable? How to manage the major challenges in funding, talent, housing, supply chain and waste stream?

Watch what happens when veteran reporter and news anchor Sandra Mi

Senior and C-Level executives from the Biotech, Life Science and Medical Device industries gathering quarterly for fireside chats — live, in person and totally off the record. We last gathered on Wed Oct 25, 2023 featuring some of the local stars of biotech. KTLA Anchor and Breast Cancer Survivor Sandra Mitchell anchored our conversations with Tom Zindrick, CEO, Genelux (NASDAQ:GNLX), a veteran biotech industry leader, spending 16 years at Amgen and serving on other biotech companies’ boards of directors; David J. Whelan, CEO, BioscienceLA – the innovation catalyst for life sciences in the region, accelerating the growth of funding, space, and talent ; and Vanessa Belozeroff, AVP, Organon (NYSE:OGN) Organon is the $6.5 bil pharma co focused on women’s health. Vanessa spent 18 years at Amgen.

RSVP Now to join us at the next BioMedLey on Oct 25 featuring some of the local stars of biotech KTLA Anchor and Breast Cancer Survivor Sandra Mitchell who will anchor our conversations with Tom Zindrick, CEO, Genelux (NASDAQ:GNLX), a veteran biotech industry leader, spending 16 years at Amgen and serving on other biotech companies’ boards of directors; David J. Whelan, CEO, BioscienceLA – the innovation catalyst for life sciences in the region, accelerating the growth of funding, space, and talent ; and Vanessa Belozeroff, AVP, Organon (NYSE:OGN) Organon is the $6.5 bil pharma co focused on women’s health. Vanessa spent 18 years at Amgen. And as always we’ll have fine classical music performed by our favorite local artists during our reception in a private home, with fine wine and world class appetizers.

Join us to wrap up the year at BioHoHo featuring a panel of experts and real Ventura County Firefighters. Just bring a toy for the Spark of Love Toy Drive!

Free to attend for senior biotech leaders (VPs and above), thanks to our Co Producers. Let us know if you want an invitation!

Private Event – Invitation Only Senior Leaders (Manager or above) in Biotech and Medical Device Companies

BioMedLey gathered Sept 20, 2022 at UBS’s Ryan Bristol’s beautiful home overlooking the Santa Monica Mountains from Thousand Oaks.

BioMedLeyers met the leaders of our local biotech and life science communities over drinks, apps and a fireside chat with the one and only Jane Wells from CNBC (and a local TO resident).

This Private Event – Invitation Only — featured Senior Leaders (Manager or above) in Biotech, Lifescience and Medical Device Companies. Featured Guests included:

• Peter Anastasiou, CEO, Capsida Biotherapeutics
• Arianne Callender, Associate General Counsel, Kite Pharma; Former Senior Counsel, Amgen
• David Lucas, COO at A2 Biotherapeutics

6-7 Reception with Tray Passed Appetizers and Drinks
7-8 Jane Wells and Local Biotech Leaders!

BioMedLey gathered in early July at a Thousand Oaks brew pub. It was a casual “buy a drink and get to know” format featuring the leaders of Arcutis Biotherapeutics. Frank Watanabe, CEO; Mas Matsuta, General Counsel and Patricia Turney, COO.

We gathered for some great craft beer, wine and appetizers. Cost to attend $44 – includes two drink tickets, hosted appetizers and a donation to Sophia’s Buddies, with funds supporting the BioMedLey Triathlon Team pediatric cancer research at Children’s Hospital Los Angeles.

Private Event – Invitation Only Senior Leaders (Manager or above) in Biotech and Medical Device Companies

Snapshot Arcutis is public (NASDAQ: ARQT), approx 200 employees, based in Westlake Village. It has completed Phase III clinical trials and is awaiting FDA review on its lead therapy for plaque psoriasis.

The biotech and life science industry is thriving on the 101 Corridor from LA to Santa Barbara thanks to Amgen, Takeda, Westlake Village Biopartners, Arcutis, Atara, Dyve Biosciences,  Cure Pharmaceuticals, Kate Farms and other leading companies in the region.

Join Jane Wells from CNBC as she interviews these leaders and hear great music from local musicians — part of the symphony who continue to help orchestrate a high quality of life here.

Headliners:

• Dr. Sean Harper, MD — Dr. Sean Harper was head of Research & Development at Amgen for many years. He’s been both a practicing physician and a research scientist.  At Westlake VIllage Biopartners Sean helps identify promising new therapies and launch companies to address unmet medical needs.
• Hosted by CNBC’s Jane Wells (local Thousand Oaks resident)
• Music Presented by local musicians

BioMedLey gathered in early July at a Thousand Oaks brew pub. It was a casual “buy a drink and get to know” format featuring the leaders of Arcutis Biotherapeutics. Frank Watanabe, CEO; Mas Matsuta, General Counsel and Patricia Turney, COO.

We gathered for some great craft beer, wine and appetizers. Cost to attend $44 – includes two drink tickets, hosted appetizers and a donation to Sophia’s Buddies, with funds supporting the BioMedLey Triathlon Team pediatric cancer research at Children’s Hospital Los Angeles.

Private Event – Invitation Only Senior Leaders (Manager or above) in Biotech and Medical Device Companies

Snapshot Arcutis is public (NASDAQ: ARQT), approx 200 employees, based in Westlake Village. It has completed Phase III clinical trials and is awaiting FDA review on its lead therapy for plaque psoriasis.

Our first BioMedLey in June of 2021 featured CNBC’s Jane Wells interviewing biotech, medical device and life science leaders. Our hosts were also featured in ads and shout outs during the broadcast, as well as local musicians. Check it out!

Featured:

• David Meline, CFO of Moderna (former Amgen CFO)
• Frank Watanabe, CEO of Arcutis Biopharmaceuticals
• Dr. Ryan Beal, CEO of Dyve Biosciences
• Tom Beecher, CEO of Kate Farms
• Dr. Na Shen from UCLA Health

Our second BioMedLey gathering was Live and In Person on November 4, 2021. We gathered at Vallavanda Manor, Vicky Rathje’s magnificent estate atop a mountain in Santa Rosa Valley, between Thousand Oaks and Camarillo.

CNBC’s Jane Wells interviewed a panel of leaders including:

• Frank Watanabe, CEO of Arcutis Biotherapeutics
• Ryan Sounders, General Counsel at Curative (the Covid-19 testing and vaccine deployment company)
• Dr. Ryan Beal, MD, CEO of Dyve Biosciences
• Aubrey Kelly, CEO of RabbleHealth
• Amie Krause, SVP and Chief People Officer at Atara Biotherapeutics
• Elaine Salewske, Head Sustainability Officer at Takeda Pharmaceuticals

Music was provided by Violist Judy Garf and Violinist Sharon Cooper.